AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $495 | +9800.0% | 78,128 | +8029.9% | 0.00% | – |
| Q1 2024 | $5 | 0.0% | 961 | +0.2% | 0.00% | – |
| Q4 2023 | $5 | 0.0% | 959 | -76.5% | 0.00% | – |
| Q1 2023 | $5 | -84.8% | 4,079 | -75.9% | 0.00% | – |
| Q4 2022 | $33 | -99.9% | 16,913 | 0.0% | 0.00% | – |
| Q3 2022 | $34,000 | -15.0% | 16,913 | +31.8% | 0.00% | – |
| Q2 2022 | $40,000 | -24.5% | 12,834 | 0.0% | 0.00% | – |
| Q1 2022 | $53,000 | -13.1% | 12,834 | 0.0% | 0.00% | – |
| Q4 2021 | $61,000 | +10.9% | 12,834 | +24.1% | 0.00% | – |
| Q3 2021 | $55,000 | +96.4% | 10,340 | +145.8% | 0.00% | – |
| Q1 2021 | $28,000 | -15.2% | 4,206 | -42.3% | 0.00% | – |
| Q4 2020 | $33,000 | -41.1% | 7,290 | -38.4% | 0.00% | – |
| Q2 2020 | $56,000 | – | 11,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |